As of June 30, 2026, Zepp Health Corporation carries a market capitalization of 76.48M, placing it among publicly traded companies globally. Its enterprise value stands at 252.80M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 76.48M |
| Enterprise Value | 252.80M |
Zepp Health Corporation's next confirmed earnings release is scheduled for November 22, 2026.
| Earnings Date | 11/22/2026 |
As of June 30, 2026, Zepp Health Corporation has 14.68M shares outstanding.
| Shares Outstanding | 14.68M |
These figures are as of June 30, 2026. The price-to-sales ratio is 0.30, and the price-to-book ratio stands at 0.41.
| PS Ratio | 0.30 |
| PB Ratio | 0.41 |
| P/TBV Ratio | 0.47 |
These figures are as of June 30, 2026. The EV/Sales ratio of 0.92 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 252.80M versus a market cap of 76.48M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 0.92 |
As of June 30, 2026, Zepp Health Corporation maintains a current ratio of 0.90, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 132.98, indicating elevated leverage, while an interest coverage ratio of -5.41 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.90 |
| Quick Ratio | 0.48 |
| Debt / Equity | 132.98 |
| Debt / EBITDA | -7.08 |
| Interest Coverage | -5.41 |
Over the twelve months ended June 30, 2026, Zepp Health Corporation posted a negative return on equity (ROE) of -21.23, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -7.86, reflecting losses generated across the asset base. The company generates approximately 361,527.18 in revenue per employee across its workforce of 763.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.38 indicates how many times Zepp Health Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -21.23 |
| Return on Assets (ROA) | -7.86 |
| Revenue Per Employee | 361,527.18 |
| Employee Count | 763.50 |
| Inventory Turnover | 2.38 |
Over the twelve months ended June 30, 2026, Zepp Health Corporation recorded 2.51M in income tax expense. The company reported a pretax loss of -38.68M and -43.56M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 2.51M |
As of the close on November 16, 2026, Zepp Health Corporation's stock has declined approximately 89.41% over the past 52 weeks. The 50-day moving average sits at 3.39, while the 200-day moving average is 9.09.
| 52-Week Price Change | -89.41% |
| 50-Day Moving Average | 3.39 |
| 200-Day Moving Average | 9.09 |
Over the twelve months ended June 30, 2026, Zepp Health Corporation generated 276.03M in revenue and converted that into -43.56M in net income, yielding earnings per share of -2.75. EBITDA reached -34.75M, while operating income came in at -34.75M.
| Revenue | 276.03M |
| Gross Profit | 106.50M |
| Operating Income | -34.75M |
| Pretax Income | -38.68M |
| Net Income | -43.56M |
| EBITDA | -34.75M |
| EBIT | -34.75M |
| Earnings Per Share (EPS) | -2.75 |
As of June 30, 2026, Zepp Health Corporation holds 69.66M in cash and equivalents against 245.98M in total debt, resulting in a net debt position of 175.25M. Total book value stands at 184.97M, with working capital of -31.86M providing operational flexibility.
| Cash & Cash Equivalents | 69.66M |
| Total Debt | 245.98M |
| Net Debt | 175.25M |
| Equity (Book Value) | 184.97M |
| Book Value Per Share | 12.60 |
| Working Capital | -31.86M |
Over the twelve months ended June 30, 2026, Zepp Health Corporation posted a gross margin of 38.58, reflecting its pricing power and cost economics. The operating margin of -12.59 and net profit margin of -15.78 provide insight into operational efficiency.
| Gross Margin | 38.58 |
| Operating Margin | -12.59 |
| Pretax Margin | -14.01 |
| Profit Margin | -15.78 |
| EBITDA Margin | -12.59 |
Zepp Health Corporation's most recent stock split took place on September 16, 2024 with a 4:1 split ratio.
| Last Split Date | 9/16/2024 |
| Split Ratio | 4:1 |
As of June 30, 2026, Zepp Health Corporation has an Altman Z-Score of 0.24, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.24 |
Already premium?